FDAs 2025 Increase in Warning Letters on Compounded Drug Advertising In recent remarks at the Food and Drug Law Institutes Enforcement, Litigation, and Compliance Conference, the director of the Office of Compliance within FDAs Center for Drug Evaluation and Research's (CDER) noted that 22% of warning letters that CDER issued in fiscal year (FY) 2025 were sent to telehealth platforms and other entities related to claims made regarding compounded drug products, including compounded GLP-1s
Rett syndrome: exploring the autism link
Participants were randomized to receive tirzepatide at doses of 5 mg, 10 mg, or 15 mg weekly, or placebo, for 176 weeks (over three years), followed by a 17-week off-treatment period
M.MalnicG.et al
For a 10mg vial, 1mL of bacteriostatic water creates a 10mg/mL concentration suitable for doses from 2mg (20 units) through 8mg (80 units)
Both drugs work best alongside lasting changes, and many people switch to a low maintenance dose rather than stopping abruptly